| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.41B | 42.15B | 38.55B | 37.21B | 34.34B | 29.58B |
| Gross Profit | 21.77B | 19.85B | 17.79B | 18.10B | 16.65B | 13.69B |
| EBITDA | 8.08B | 6.58B | 5.33B | 6.88B | 6.57B | 4.57B |
| Net Income | 4.52B | 3.38B | 2.96B | 3.74B | 3.78B | 2.46B |
Balance Sheet | ||||||
| Total Assets | 72.77B | 67.29B | 66.84B | 54.93B | 50.18B | 45.81B |
| Cash, Cash Equivalents and Short-Term Investments | 23.61B | 20.07B | 20.80B | 15.68B | 15.18B | 14.71B |
| Total Debt | 4.23B | 4.89B | 5.83B | 842.50M | 1.25B | 1.66B |
| Total Liabilities | 17.93B | 16.03B | 19.19B | 11.90B | 11.18B | 10.45B |
| Stockholders Equity | 50.94B | 47.65B | 44.37B | 40.14B | 36.52B | 33.37B |
Cash Flow | ||||||
| Free Cash Flow | 7.15B | 708.89M | 644.03M | 1.18B | 2.47B | 3.08B |
| Operating Cash Flow | 8.41B | 4.89B | 2.55B | 2.62B | 3.30B | 3.73B |
| Investing Cash Flow | -2.17B | -4.73B | -2.32B | -1.49B | -2.20B | -675.41M |
| Financing Cash Flow | -2.38B | -1.67B | 4.27B | -1.01B | -990.73M | -364.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥58.53B | 9.58 | ― | 1.12% | 14.84% | 7.57% | |
80 Outperform | ¥27.43B | 13.32 | ― | 2.89% | 6.15% | 2.98% | |
80 Outperform | ¥70.08B | 8.26 | ― | 2.31% | 6.50% | 30.54% | |
79 Outperform | ¥101.26B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
75 Outperform | ¥70.58B | 12.98 | ― | 3.12% | 2.78% | -5.32% | |
72 Outperform | ¥23.12B | 7.24 | ― | 2.84% | 8.78% | 16.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |